In a significant decision that clarifies the standards for determining controlling stockholder status, the Delaware Court of Chancery dismissed claims against AstraZeneca and Viela Bio’s directors in connection with Viela’s $ 3 billion sale to Horizon Therapeutics. The case, Sciannella v. AstraZeneca UK Limited et al., addressed whether AstraZeneca, which held a 26.7% stake in Viela, exercised control over the company and whether the merger was subject to business judgment review under Corwin v. KKR Financial Holdings LLC. Vice … Read the rest
Establishing the true cause of the accident is essential because you need to know who to sue, the driver or the trucking company.
Legal Reader… Read the rest